DK0492560T3 - Human, monoklonale antistoffer rettet imod transmembranglycoproteinet (gp41) af HIV-1 og beslægtede peptider - Google Patents
Human, monoklonale antistoffer rettet imod transmembranglycoproteinet (gp41) af HIV-1 og beslægtede peptiderInfo
- Publication number
- DK0492560T3 DK0492560T3 DK91122041T DK91122041T DK0492560T3 DK 0492560 T3 DK0492560 T3 DK 0492560T3 DK 91122041 T DK91122041 T DK 91122041T DK 91122041 T DK91122041 T DK 91122041T DK 0492560 T3 DK0492560 T3 DK 0492560T3
- Authority
- DK
- Denmark
- Prior art keywords
- hiv
- antibody
- human monoclonal
- peptide
- fusion
- Prior art date
Links
- 241000713772 Human immunodeficiency virus 1 Species 0.000 title abstract 5
- 101800001690 Transmembrane protein gp41 Proteins 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108091007466 transmembrane glycoproteins Proteins 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 238000002965 ELISA Methods 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 230000004927 fusion Effects 0.000 abstract 2
- 230000003472 neutralizing effect Effects 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000036436 anti-hiv Effects 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/633,964 US5459060A (en) | 1989-08-24 | 1990-12-26 | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0492560T3 true DK0492560T3 (da) | 2001-11-12 |
Family
ID=24541883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91122041T DK0492560T3 (da) | 1990-12-26 | 1991-12-21 | Human, monoklonale antistoffer rettet imod transmembranglycoproteinet (gp41) af HIV-1 og beslægtede peptider |
Country Status (6)
Country | Link |
---|---|
US (2) | US5459060A (da) |
EP (2) | EP1016671A3 (da) |
AT (1) | ATE206620T1 (da) |
DE (1) | DE69132762T2 (da) |
DK (1) | DK0492560T3 (da) |
ES (1) | ES2164635T3 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19622088A1 (de) * | 1996-05-31 | 1997-12-04 | Boehringer Mannheim Gmbh | Anti-HIV-Antikörper als Kontrollproben |
JP2002505097A (ja) * | 1998-03-03 | 2002-02-19 | アブジェニックス インク. | 治療薬としてのcd147結合分子 |
US6197582B1 (en) | 1998-03-18 | 2001-03-06 | The Trustees Of Columbia University In The City Of New York | Development of human monoclonal antibodies and uses thereof |
US7090848B1 (en) * | 1998-08-04 | 2006-08-15 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | HIV-1 envelope protein associated with a broadly reactive neutralizing antibody response |
US6596497B1 (en) * | 1999-03-17 | 2003-07-22 | New York Blood Center, Inc. | Screening of antiviral compounds targeted to the HIV-1 gp41 core structure |
CN1172717C (zh) * | 2000-08-18 | 2004-10-27 | 清华大学 | 一种治疗艾滋病的药物及其制备方法 |
US7060802B1 (en) * | 2000-09-18 | 2006-06-13 | The Trustees Of Columbia University In The City Of New York | Tumor-associated marker |
AU2002244968B2 (en) * | 2001-04-05 | 2007-07-26 | Astellas Pharma Inc. | Anti-osteopontin antibody and use thereof |
CA2357906A1 (en) * | 2001-09-28 | 2003-03-28 | Institut Pasteur | Identification of new cd8 epitopes from hiv-1 proteins with therapeutical and vaccinal properties against hiv infections |
CN1238499C (zh) * | 2002-07-29 | 2006-01-25 | 清华大学 | 艾滋病病毒0型株的一种抗体及其生产细胞系与应用 |
CN1472314A (zh) * | 2002-07-29 | 2004-02-04 | 清华大学 | 艾滋病病毒o型株的一个免疫学表位及其应用 |
US7744887B2 (en) * | 2004-06-01 | 2010-06-29 | Merck & Co., Inc. | Human antibodies interacting with HIV gp41 |
AU2005335203A1 (en) * | 2004-09-08 | 2007-02-15 | The United States Of America As Represented By The Secretary Of Health And Human Services, Nih | Compositions and methods for the detection of HIV-1/HIV-2 infection |
WO2006117584A1 (en) * | 2005-05-02 | 2006-11-09 | Institut National De La Sante Et De La Rehcerche Medicale | Antibody or a fragment thereof, having neutralizing activity against hiv |
CN108779168A (zh) | 2015-12-05 | 2018-11-09 | 沃迪奥斯大学医院中心 | Hiv结合剂 |
WO2020012435A1 (en) | 2018-07-13 | 2020-01-16 | Lausanne University Hospital | Hiv binding agents |
EP3996815A2 (en) | 2019-07-15 | 2022-05-18 | Lausanne University Hospital | Hiv binding agents |
AU2022238882A1 (en) | 2021-03-18 | 2023-10-19 | Gaurav Chandra | Human immunodeficiency virus (hiv) antigens and epitopes and proteins that bind thereto |
WO2023043880A1 (en) | 2021-09-16 | 2023-03-23 | Cotropia Joseph | Hiv-binding peptides and medical use thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
US4755457A (en) * | 1985-02-05 | 1988-07-05 | Robert Guroff Marjorie | Method for detecting HTLV-III neutralizing antibodies in sera |
US4722888A (en) * | 1985-03-29 | 1988-02-02 | United States Of America As Represented By The Department Of Health And Human Services | Cell line producing human monoclonal antibody which binds to HTLV-I producing cells |
CS256960B1 (en) * | 1985-11-16 | 1988-04-15 | Viktor Krchnak | Peptides with properties of antigenic determinants and method of their production |
US4761470A (en) * | 1985-12-16 | 1988-08-02 | Merck & Co., Inc. | Immunogenic synthetic peptide capable of eliciting herpes simplex virus neutralizing antibody |
US4839288A (en) * | 1986-01-22 | 1989-06-13 | Institut Pasteur | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
WO1987006005A1 (en) * | 1986-03-24 | 1987-10-08 | Ortho Pharmaceutical Corporation | Synthetic htlv-iii peptides, compositions and uses thereof |
US5087557A (en) * | 1986-06-23 | 1992-02-11 | Genetic Systems Corporation | Human monoclonal antibody to lymphadenopathy-associated virus |
US4833071A (en) * | 1987-01-09 | 1989-05-23 | United Biomedical, Inc. | Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor |
DE3887053T4 (de) * | 1987-04-16 | 1994-09-08 | Johnson & Johnson | Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden. |
US4812556A (en) * | 1987-05-18 | 1989-03-14 | Virovahl | Synthetic peptide antigen for the detection of HIV-2 infection |
EP0316495A1 (en) * | 1987-11-19 | 1989-05-24 | Iaf Biochem International Inc. | Synthetic peptides useful for the detection of aids-related antibodies in human sera |
KR960013600B1 (ko) * | 1989-06-02 | 1996-10-09 | 제네틱 시스팀스 코포레이션 | 면역분석법에 이용되는 시스테인 티올-보호 펩티드 |
-
1990
- 1990-12-26 US US07/633,964 patent/US5459060A/en not_active Expired - Lifetime
-
1991
- 1991-12-21 AT AT91122041T patent/ATE206620T1/de not_active IP Right Cessation
- 1991-12-21 DK DK91122041T patent/DK0492560T3/da active
- 1991-12-21 EP EP00102215A patent/EP1016671A3/en not_active Withdrawn
- 1991-12-21 EP EP91122041A patent/EP0492560B1/en not_active Expired - Lifetime
- 1991-12-21 DE DE69132762T patent/DE69132762T2/de not_active Expired - Lifetime
- 1991-12-21 ES ES91122041T patent/ES2164635T3/es not_active Expired - Lifetime
-
1995
- 1995-02-10 US US08/386,956 patent/US5777074A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5777074A (en) | 1998-07-07 |
EP0492560A2 (en) | 1992-07-01 |
ATE206620T1 (de) | 2001-10-15 |
ES2164635T3 (es) | 2002-03-01 |
EP0492560B1 (en) | 2001-10-10 |
EP1016671A3 (en) | 2000-08-02 |
US5459060A (en) | 1995-10-17 |
DE69132762D1 (de) | 2001-11-15 |
EP0492560A3 (en) | 1993-02-10 |
DE69132762T2 (de) | 2002-07-11 |
EP1016671A2 (en) | 2000-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0492560T3 (da) | Human, monoklonale antistoffer rettet imod transmembranglycoproteinet (gp41) af HIV-1 og beslægtede peptider | |
Bettaieb et al. | Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura | |
DI MARZO VERONESE et al. | Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15 | |
Moore et al. | Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans | |
Moore et al. | Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies | |
EP0387914B1 (en) | Envelope antigens of the human immuno-deficiency virus, and their applications | |
AU632475B2 (en) | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals | |
Palker et al. | Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins | |
Ikuta et al. | Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens | |
Yang et al. | Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1 | |
EA200100943A1 (ru) | Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител | |
Lohman et al. | Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay | |
US7087377B2 (en) | Method and kit for detection of tat protein with anti-tat oyi antibodies | |
CHIRMULE et al. | Localization of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41 | |
McKEATING et al. | Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site | |
US6042831A (en) | Human immunodeficiency virus type 1 (HIV-1) GP160 epitopes that are immunologically homologous to epitopes located in the class I major histocompatibility complex (MHC) heavy chain α-1 domain | |
KR910002690B1 (ko) | Htlv-ⅲ 바이러스 관련 펩티드, 이에 대한 항체, 백신, aids바이러스에 대한 수동 및 자동 면역 및 aids바이러스의 혈청학적 진단을 위한 진단 시험 | |
NORRBY et al. | Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1 | |
ES2071626T3 (es) | Anticuerpo monoclonal de raton contra la proteina gp41 del virus de inmunodeficiencia humana. | |
Liao et al. | Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains | |
Bugge et al. | Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody | |
US5338829A (en) | Peptides derived from human immunodeficiency virus-1 GP160 | |
WO1989010416A1 (en) | PROTECTIVE PEPTIDES DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS-1 gp160 | |
Eberle et al. | Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection | |
Sørensen et al. | Correlation of antibody responses to a peptide antigen gp120-C5501–512/gp41732–744 with HIV disease progression |